Micronutrients in psychiatric and neurodevelopmental disorders
Precision and Future Medicine · 30.06.2026 · 10 (2) · 77-89
DOI: 10.23838/pfm.2026.00079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision and Future Medicine, erschienen am 30.06.2026. Verfasst von Hyejin Kim und 11 weiteren Autor:innen. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
Micronutrients are essential for brain function, but whether their reported associations with psychiatric and neurodevelopmental disorders are causal remains unclear. We evaluated these associations systematically by integrating evidence from an umbrella review and Mendelian randomization (MR) analyses.
Methods
Systematic searches of PubMed and Embase (PROSPERO CRD42023468700) identified 26 eligible meta-analyses of observational studies. MR analyses examined 14 micronutrients and 12 disorders using genome-wide association summary statistics from individuals of European ancestry, with sensitivity analyses including weighted median, MR-Egger, and MR-PRESSO.
Results
Among 168 micronutrient–disorder associations, none reached statistical significance in both observational and MR analyses. Several associations showed directionally consistent patterns across independent observational studies or between observational and MR results, but only zinc–autism spectrum disorder (ASD) and vitamin D–major depressive disorder (MDD) were concordant across both evidence streams. Individuals with ASD had lower circulating zinc levels than controls (standardized mean difference, –0.36; 95% confidence interval [CI], –0.67 to –0.05), while genetically predicted higher zinc levels showed a suggestive association with lower ASD risk (odds ratio [OR], 0.91; 95% CI, 0.83 to 1.00; P= 0.055). For vitamin D–MDD, observational evidence indicated lower serum vitamin D levels in MDD (Hedges’ g, –0.35; 95% CI, –0.49 to –0.20), with a concordant but non-significant MR estimate (OR, 0.92; 95% CI, 0.83 to 1.01; P= 0.085).
Conclusion
MR provided limited evidence for causality, suggesting that observed micronutrient differences may largely reflect the downstream effects of psychiatric illness. Zinc–ASD and vitamin D–MDD warrant further longitudinal and interventional investigation.
Zitieren
APA
Kim, H., Kim, J. Y., Jung, K., Kim, M. S., Song, M., Kim, D. S., Natarajan, P., Do, R., Dragioti, E., Shin, J. I., Myung, W., & Won, H. (2026). Micronutrients in psychiatric and neurodevelopmental disorders. Precision and Future Medicine, 10(2), 77-89. https://doi.org/10.23838/pfm.2026.00079
Vancouver
Kim H, Kim JY, Jung K, Kim MS, Song M, Kim DS, et al. Micronutrients in psychiatric and neurodevelopmental disorders. Precision and Future Medicine. 2026;10(2):77-89. doi:10.23838/pfm.2026.00079
BibTeX
@article{Kim2026,
author = {Kim, Hyejin and Kim, Jong Yeob and Jung, Kyeongmin and Kim, Min Seo and Song, Minku and Kim, Dan Say and Natarajan, Pradeep and Do, Ron and Dragioti, Elena and Shin, Jae Il and Myung, Woojae and Won, Hong-Hee},
title = {Micronutrients in psychiatric and neurodevelopmental disorders},
journal = {Precision and Future Medicine},
year = {2026},
volume = {10},
number = {2},
pages = {77--89},
doi = {10.23838/pfm.2026.00079}
}
EUVIMED